Innovative Approaches to Control Hypertension: Systematic Review
Adam Alaqeel *
Department of Internal Medicine, College of Medicine, Imam Abdulrahman Bin Faisal University, Khobar, Saudi Arabia.
*Author to whom correspondence should be addressed.
Abstract
One of the leading causes of death and disability worldwide, high blood pressure is thought to have killed over 10 million people. One of the main goals of global health care is to improve the control of hypertension. Another significant risk factor for the majority of cardiac disorders is hypertension. Modern methods of controlling hypertension demand collaborative efforts from the patient, family, community, and health care providers. The researcher found after doing a thorough review of the literature that new methods of controlling hypertension are still being developed. It consists of surgical, technological, pharmaceutical, and non-pharmaceutical methods.
Keywords: Hypertension control, high blood pressure, diastolic blood pressure, physiological stress
How to Cite
Downloads
References
Mercer T, Nulu S, Vedanthan R. Innovative implementation strategies for hypertension control in low- and middle-income countries: A narrative review. Current hypertension reports. 2020;22(5):39.
Available:https://doi.org/10.1007/s11906-020-01045-1
World Health Organization. A global brief on hypertension: Silent killer, global public health crisis: World Health Day 2013. World Health Organization; (2013). Available:https://apps.who.int/iris/handle/10665/79059
Kitt J, Fox R, Tucker KL, McManus RJ. New approaches in hypertension management: A review of current and developing technologies and their potential impact on hypertension care. Current hypertension reports. 2019;21(6):44. Available:https://doi.org/10.1007/s11906-019-0949-4
Carey RM, Whelton PK, ACC/AHA hypertension guideline writing committee (2018). Prevention, Detection, Evaluation, and Management of High Blood Pressure in Adults: Synopsis of the 2017 American College of Cardiology/American Heart Association Hypertension Guideline. Annals of internal medicine. 2017; 168(5):351–358.
Available:https://doi.org/10.7326/M17-3203
Strait JB, Lakatta EG. Aging-associated cardiovascular changes and their relationship to heart failure. Heart failure clinics. 2012;8(1):143–164. Available:https://doi.org/10.1016/j.hfc.2011.08.011
Trtica Majnarić L, Martinović I, Šabanović Š, Rudan S, Babič F, Wittlinger T. The effect of hypertension duration and the age of onset on CV risk factors expression in perimenopausal women. International journal of hypertension. 2019;9848125. Available:https://doi.org/10.1155/2019/9848125
Forouzanfar MH, Liu P, Roth GA, Ng M, Biryukov S, Marczak L, Alexander L, Estep K, Abate KH, Akinyemiju TF, Ali R. Global burden of hypertension and systolic blood pressure of at least 110 to 115 mm Hg, 1990-2015. Jama. 2017;317(2):165-82.
Mahmood S, Shah KU, Khan TM, Nawaz S, Rashid H, Baqar SWA, Kamran S. Non-pharmacological management of hypertension: in the light of current research. Irish journal of medical science. 2019;188(2):437–452.
Available:https://doi.org/10.1007/s11845-018-1889-8
Zhou B, Perel P, Mensah GA, Ezzati M. Global epidemiology, health burden and effective interventions for elevated blood pressure and hypertension. Nature reviews. Cardiology. 2021;18(11):785–802.
Available:https://doi.org/10.1038/s41569-021-00559-8
Williams B, Mancia G, Spiering W, Agabiti Rosei E, Azizi M, Burnier M, Authors/task force members: 2018 ESC/ESH guidelines for the management of arterial hypertension: the task force for the management of arterial hypertension of the european society of cardiology and the european society of hypertension: the task force for the management of arterial hypertension of the European Society of Cardiology and the European Society of Hypertension. Journal of hypertension. 2018;36(10):1953–2041. Available:https://doi.org/10.1097/HJH.0000000000001940
Derington CG, King JB, Herrick JS, Shimbo D, Kronish IM, Saseen JJ, Muntner P, Moran AE, Bress AP. Trends in antihypertensive medication monotherapy and combination use among US adults, national health and nutrition examination survey 2005-2016. Hypertension (Dallas, Tex. : 1979). 2020;75(4):973–981.
Available:https://doi.org/10.1161/HYPERTENSIONAHA.119.14360
Tanase DM, Gosav EM, Radu S, Ouatu A, Rezus C, Ciocoiu M, Costea CF, Floria M. Arterial Hypertension and Interleukins: Potential Therapeutic Target or Future Diagnostic Marker?. International journal of hypertension. 2019;3159283. Available:https://doi.org/10.1155/2019/3159283
Ballicora MA, Iglesias AA, Preiss J. ADP-glucose pyrophosphorylase, a regulatory enzyme for bacterial glycogen synthesis. Microbiology and molecular biology reviews : MMBR. 2003;67(2):213–225.
Available:https://doi.org/10.1128/MMBR.67.2.213-225.2003
Melendez QM, Krishnaji ST, Wooten CJ, Lopez D. Hypercholesterolemia: The role of PCSK9. archives of biochemistry and biophysics. 2017;625-626:39–53. Available:https://doi.org/10.1016/j.abb.2017.06.001
Dzau VJ, Balatbat CA. Future of Hypertension. Hypertension (Dallas, Tex. : 1979). 2019;74(3):450–457.
Available:https://doi.org/10.1161/HYPERTENSIONAHA.119.13437
Wang X, Raghavan A, Chen T, Qiao L, Zhang Y, Ding Q, Musunuru K. CRISPR-Cas9 Targeting of PCSK9 in human hepatocytes In vivo-brief report. Arterioscler Thromb Vasc Biol. 2016; 36(5):783-6.
DOI: 10.1161/ATVBAHA.116.307227. Epub 2016 Mar 3. PMID: 26941020; PMCID: PMC4850082.
Wang L, Smith J, Breton C, Clark P, Zhang J, Ying L, Che Y, Lape J, Bell P, Calcedo R, Buza EL, Saveliev A, Bartsevich VV, He Z, White J, Li M, Jantz D, Wilson JM. Meganuclease targeting of PCSK9 in macaque liver leads to stable reduction in serum cholesterol. Nat Biotechnol. 2018;36(8):717-725.
DOI: 10.1038/nbt.4182. Epub 2018 Jul 9. PMID: 29985478.
Selçuk KT, Çevik C, Mercan Y, Koca H. Hypertensive patients’ adherence to pharmacological and non-pharmacological treatment methods, in Turkey. International Journal of Community Medicine and Public Health. 2017;4(8):2648–2657. Available:https://doi.org/10.18203/2394-6040.ijcmph20173308
Azadbakht L, Fard NR, Karimi M, Baghaei MH, Surkan PJ, Rahimi M, Esmaillzadeh A, Willett WC. Effects of the dietary approaches to stop hypertension (DASH) eating plan on cardiovascular risks among type 2 diabetic patients: a randomized crossover clinical trial. Diabetes care. 2011;34(1):55–57.
Available:https://doi.org/10.2337/dc10-0676
Saneei P, Salehi-Abargouei A, Esmaillzadeh A, Azadbakht L. Influence of dietary approaches to stop hypertension (DASH) diet on blood pressure: A systematic review and meta-analysis on randomized controlled trials. Nutrition, metabolism, and cardiovascular diseases: NMCD. 2014;24(12):1253– 1261. Available:https://doi.org/10.1016/j.numecd.2014.06.008
Van Horn L. Dietary sodium and blood pressure: How low should we go?. Progress in cardiovascular diseases. 2015;58(1):61–68. Available:https://doi.org/10.1016/j.pcad.2015.05.008
Rodrigo R, Gil D, Miranda-Merchak A, Kalantzidis G. Antihypertensive role of polyphenols. Advances in clinical chemistry. 2012;58:225–254. Available:https://doi.org/10.1016/b978-0-12-394383-5.00014-x
Rodrigo R, González-Montero J, Sotomayor CG. Novel combined antioxidant strategy against hypertension, acute myocardial infarction and postoperative atrial fibrillation. Biomedicines. 2021;9(6):620.
Available:https://doi.org/10.3390/biomedicines9060620
Xin X, He J, Frontini MG, Ogden LG, Motsamai OI, Whelton PK. Effects of alcohol reduction on blood pressure: a meta-analysis of randomized controlled trials. Hypertension (Dallas, Tex. : 1979). 2001;38(5):1112–1117.
Available:https://doi.org/10.1161/hy1101.093424
Faselis C, Doumas M, Kokkinos JP, Panagiotakos D, Kheirbek R, Sheriff HM, Hare K, Papademetriou V, Fletcher R, Kokkinos P. Exercise capacity and progression from prehypertension to hypertension. Hypertension (Dallas, Tex. : 1979). 2012;60(2):333–338. Available:https://doi.org/10.1161/HYPERTENSIONAHA.112.196493
Cornelissen VA, Fagard RH, Coeckelberghs E, Vanhees L. Impact of resistance training on blood pressure and other cardiovascular risk factors: a meta-analysis of randomized, controlled trials. Hypertension (Dallas, Tex.: 1979). 2011;58(5):950–958. Available:https://doi.org/10.1161/HYPERTENSIONAHA.111.177071
Grassi G. Assessment of sympathetic cardiovascular drive in human hypertension: achievements and perspectives. Hypertension (Dallas, Tex.: 1979). 2009;54(4):690–697.
Available:https://doi.org/10.1161/HYPERTENSIONAHA.108.119883
Ordunez P, Campbell NRC, Giraldo Arcila GP, Angell SY, Lombardi C, Brettler JW, Rodriguez Morales YA, Connell KL, Gamarra A, DiPette DJ, Rosende A, Jaffe MG, Rodriguez L, Piñeiro DJ, Martinez R, Sharman JE. HEARTS en las Américas: innovaciones para mejorar el manejo del riesgo de hipertensión y enfermedades cardiovasculares en la atención primaria. Revista Panamericana de Salud Publica/Pan American Journal of Public Health. 2022;46:[e96].
Available:https://doi.org/10.26633/RPSP.2022.96
Fadlilah S, Erwanto R, Sucipto A, Anita DC, Aminah S. Soak feet with warm water and progressive muscle relaxation therapy on blood pressure in hypertension elderly. Pakistan Journal of Medical and Health Sciences. 2020;14(3): 1444-1448.
Calhoun DA, Jones D, Textor S, Goff DC, Murphy TP, Toto RD, White A, Cushman WC, White W, Sica D, Ferdinand K, Giles TD, Falkner B, Carey RM, American Heart Association Professional Education Committee. Resistant hypertension: diagnosis, evaluation, and treatment: A scientific statement from the American Heart Association Professional Education Committee of the Council for High Blood Pressure Research. Circulation. 2008; 117(25):e510–e526. Available:https://doi.org/10.1161/CIRCULATIONAHA.108.189141
Papademetriou V, Doumas M, Tsioufis K. Renal sympathetic denervation for the treatment of difficult-to-control or resistant hypertension. International journal of hypertension. 2011;196518.
Available:https://doi.org/10.4061/2011/196518
Feugier Y, Workineh P, Harbaoui S, Bricca B, G, Lantelme P. Baroreceptor stimulation for resistant hypertension: First implantation in France and literature review. Archives of cardiovascular diseases. 2014;107(12):690–696.
Available:https://doi.org/10.1016/j.acvd.2014.08.002
Jindal D, Gupta P, Jha D, Ajay VS, Goenka S, Jacob P, Mehrotra K, Perel P, Nyong J, Roy A, Tandon N, Prabhakaran D, Patel V. Development of mWellcare: An mHealth intervention for integrated management of hypertension and diabetes in low-resource settings. Global health action. 2018;11(1): 1517930.
Available:https://doi.org/10.1080/16549716.2018.1517930
Venkataraman K, Kannan AT, Mohan V. Challenges in diabetes management with particular reference to India. International journal of diabetes in developing countries. 2009;29(3):103–109.
Available:https://doi.org/10.4103/0973-3930.54286
Berntson J, Stewart KR, Vrany E, Khambaty T, Stewart JC. Depressive symptoms and self-reported adherence to medical recommendations to prevent cardiovascular disease: NHANES 2005-2010. Social science & medicine. 2015; 138:74–81. Available:https://doi.org/10.1016/j.socscimed.2015.05.041
Anchala R, Pinto MP, Shroufi A, Chowdhury R, Sanderson J, Johnson L, Blanco P, Prabhakaran D, Franco OH. The role of Decision Support System (DSS) in prevention of cardiovascular disease: a systematic review and meta-analysis. PLoS One. 2012;7(10):e47064.
DOI: 10.1371/journal.pone.0047064. Epub 2012 Oct 10. PMID: 23071713; PMCID: PMC3468543.
Omboni S, Ferrari R. The role of telemedicine in hypertension management: Focus on blood pressure telemonitoring. Current hypertension reports. 2015; 17(4):535. Available:https://doi.org/10.1007/s11906-015-0535-3
Levine DM, Dixon RF, Linder JA. Association of structured virtual visits for hypertension follow-up in primary care with blood pressure control and use of clinical services. Journal of general internal medicine. 2018;33(11):1862–1867.
Available:https://doi.org/10.1007/s11606-018-4375-0
Krittanawong C, Bomback AS, Baber U, Bangalore S, Messerli FH, Wilson Tang WH. Future direction for using artificial intelligence to predict and manage hypertension. Current hypertension reports. 2018;20(9):75.
Available:https://doi.org/10.1007/s11906-018-0875-x
Matsuoka R, Akazawa H, Kodera S, et al. The dawning of the digital era in the management of hypertension. Hypertens Res. 2020;43:1135–1140. Available:https://doi.org/10.1038/s41440-020-0506-1